{"id":"W2136845772","doi":"10.1182/blood-2002-07-1947","title":"Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Mucositis; CD33; Refractory (planetary science); Myeloid leukemia; Internal medicine; Surgery; Hematopoietic stem cell transplantation; Leukemia; Hepatic veno-occlusive disease; Transplantation; Gastroenterology; Chemotherapy; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004221961,0.0006143788,0.000805182,0.0001843536,0.000440852,0.0003593324,0.0003117048,0.0005513401,0.0005140305],"category_scores_gemma":[0.0007054937,0.000158211,0.0005175042,0.0002672134,0.0004738509,0.000275834,0.0004314801,0.0009025834,0.0002418359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005556862,"about_ca_system_score_gemma":0.0002920887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114201,"about_ca_topic_score_gemma":0.001610729,"domain_scores_codex":[0.999721,0.0001004133,0.00002901232,0.00004565529,0.00002811526,0.00007587277],"domain_scores_gemma":[0.9996638,0.00008256515,0.00006482306,0.00002760448,0.00001496916,0.0001461765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02134794,0.009767137,0.2250346,0.00145514,0.001018353,0.06931439,0.009427795,0.005499383,0.1016718,0.001245732,0.005127666,0.54909],"study_design_scores_gemma":[0.008419611,0.1784841,0.5015149,0.0002501717,0.001387756,0.1925392,0.0016391,0.004114465,0.06202886,0.000726759,0.0487396,0.0001555888],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933292,0.0045195,0.0007034369,0.0001864778,0.00001409273,0.00009418984,0.0001301499,0.00003940078,0.0009835402],"genre_scores_gemma":[0.9941478,0.003525597,0.001275986,0.0002320522,0.00005707178,0.00007519306,0.0003547385,0.00001848829,0.0003131402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00114201,"threshold_uncertainty_score":0.004031777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0232135026180305,"score_gpt":0.2762754834077394,"score_spread":0.2530619807897089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}